Understanding dosing: Children are small adults, neonates are immature children

Archives of Disease in Childhood

Volumn 98, Issue 9, 2013, Pages 737-744

  Anderson, Brian J ^a   Holford, Nick H G ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; BRONCHODILATING AGENT; BUPIVACAINE; BUSULFAN; DEXMEDETOMIDINE; GENTAMICIN; GLUCURONIDE; LEVOBUPIVACAINE; MIDAZOLAM; MORPHINE; PARACETAMOL; PROKINETIC AGENT; PROPOFOL; REMIFENTANIL; VANCOMYCIN;

ALLOMETRY; BASAL METABOLIC RATE; BODY COMPOSITION; BODY SIZE; BODY SURFACE; BODY WEIGHT; CHILDHOOD OBESITY; CONCENTRATION RESPONSE; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE; DRUG ELIMINATION; EXTRACELLULAR FLUID; GLOMERULUS FILTRATION RATE; HUMAN; IMMATURITY; INTESTINE TRANSIT TIME; MATURATION; PEDIATRIC ANESTHESIA; PERINATAL PERIOD; PHARMACODYNAMIC; PHARMACODYNAMICS; PHARMACOGENETICS; PHARMACOKINETICS; PRIORITY JOURNAL; REVIEW; STOMACH EMPTYING;

ALLOMETRY; NEONATOLOGY; OBESITY; PHARMACOLOGY; THERAPEUTICS;

ADULT; AGE FACTORS; BODY WEIGHT; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DOSAGE CALCULATIONS; HUMANS; INFANT, NEWBORN; PHARMACOKINETICS;

EID: 84883060616     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2013-303720     Document Type: Review

References (43)

1. Koren G, Barzilay Z, Greenwald M. Tenfold errors in administration of drug doses: a neglected iatrogenic disease in pediatrics. Pediatrics 1986;77:848-9.
2. Anderson BJ, Holford NH. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol 2008;48:303-32.
3. Holford NH. The target concentration approach to clinical drug development. Clin Pharmacokinet 1995;29:287-91.
4. Dawson WT. Relations between age and weight and dosages of drugs. Ann Intern Med 1940;13:1594-613.
5. Holford NH. A size standard for pharmacokinetics. Clin Pharmacokinet 1996;30:329-32.
6. Menson EN, Walker AS, Sharland M, et al. Underdosing of antiretrovirals in UK and Irish children with HIV as an example of problems in prescribing medicines to children, 1997-2005: cohort study. BMJ 2006;332:1183-7.
7. Polgar G, Weng TR. The functional development of the respiratory system from the period of gestation to adulthood. Am Rev Respir Dis 1979;120:625-95.
8. Rigby-Jones AE, Priston MJ, Sneyd JR, et al. Remifentanil-midazolam sedation for paediatric patients receiving mechanical ventilation after cardiac surgery. Br J Anaesth 2007;99:252-61.
9. West D, West BJ. Physiologic time: a hypothesis. Physics of Life Reviews 2013;10:210-24.
10. Sarrus F, Rameaux JF. Mémoire adressé à l'Académie Royale. Bull Acad Roy Med Belg 1839;3:1094.
11. Crawford JD, Terry ME, Rourke GM. Simplification of drug dosage calculation by application of the surface area principle. Pediatrics 1950;5:783-90.
12. Meeh K. Oberflachenmessungen des menschlichen Korpers,. Z Biol 1879;15:426-58.
13. McMahon TA. Scaling physiological time. Lect Math Life Sci 1980;13:131-3.
14. West GB, Brown JH. The origin of allometric scaling laws in biology from genomes to ecosystems: towards a quantitative unifying theory of biological structure and organization. J Exp Biol 2005;208:1575-92.
15. Rhodin MM, Anderson BJ, Peters AM, et al. Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr Nephrol 2009;24:67-76.
16. Chantler PD, Clements RE, Sharp L, et al. The influence of body size on measurements of overall cardiac function. Am J Physiol Heart Circ Physiol 2005;289:H2059-65.
17. Vinet A, Mandigout S, Nottin S, et al. Influence of body composition, hemoglobin concentration, and cardiac size and function of gender differences in maximal oxygen uptake in prepubertal children. Chest 2003;124:1494-9.
18. West GB, Brown JH, Enquist BJ. A general model for the origin of allometric scaling laws in biology. Science 1997;276:122-6.
19. Johnson TN, Tucker GT, Tanner MS, et al. Changes in liver volume from birth to adulthood: A meta-analysis. Liver Transpl 2005;11:1481-93.
20. Dinkel E, Ertel M, Dittrich M, et al. Kidney size in childhood. Sonographical growth charts for kidney length and volume. Pediatr Radiol 1985;15:38-43.
21. Holford NH, Ma SC, Anderson BJ. Prediction of morphine dose in humans. Paediatr Anaesth 2012;22:209-22.
22. Anderson BJ, Holford NHG. Tips and traps analyzing pediatric PK data. Pediatr Anesth 2011;21:222-37.
23. Holford N, Heo Y-A, Anderson B. A pharmacokinetic standard for babies and adults. J Pharm Sci 2013: EPub 6 May doi: 10.1002/jps.23574
24. West GB, Brown JH, Enquist BJ. The fourth dimension of life: fractal geometry and allometric scaling of organisms. Science 1999;284:1677-9.
25. Janmahasatian S, Duffull SB, Ash S, et al. Quantification of lean bodyweight. Clin Pharmacokinet 2005;44:1051-65.
26. Han PY, Duffull SB, Kirkpatrick CM, et al. Dosing in obesity: a simple solution to a big problem. Clin Pharmacol Ther 2007;82:505-8.
27. Holford NHG, McCune J, Barrett J, et al. Busulfan pharmacokinetics in neonates, infants, children and adults. Brisbane: PAGANZ, 2013.
28. Anderson BJ, Holford NHG. Mechanistic basis of using body size and maturation to predict clearance in humans. Drug Metab Pharmacokinet 2009;24:25-36.
29. Mulla H, Johnson TN. Dosing dilemmas in obese children. Arch Dis Child Educ Pract Ed 2010;95:112-17.
30. Cortinez LI, Anderson BJ, Penna A, et al. Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model. Br J Anaesth 2010;105:448-56.
31. Schuttler J, Ihmsen H. Population pharmacokinetics of propofol: a multicenter study. Anesthesiology 2000;92:727-38.
32. Diepstraten J, Chidambaran V, Sadhasivam S, et al. Propofol clearance in morbidly obese children and adolescents: influence of age and body size. Clin Pharmacokinet 2012;51:543-51.
33. Egan TD, Huizinga B, Gupta SK, et al. Remifentanil pharmacokinetics in obese versus lean patients. Anesthesiology 1998;89:562-73.
34. Berde C. Convulsions associated with pediatric regional anesthesia. Anesth Analg 1992;75:164-6.
35. Hines RN. Developmental expression of drug metabolizing enzymes: Impact on disposition in neonates and young children. Int J Pharm 2012.
36. Anderson BJ. Developmental pharmacology; filling one knowledge gap in pediatric anesthesiology. Pediatr Anesth 2011;21:179-82.
37. Schwartz GJ. Does kL/PCr estimate GFR, or does GFR determine k? Pediatr Nephrol 1992;6:512-5.
38. Vet NJ, de Hoog M, Tibboel D, et al. The effect of critical illness and inflammation on midazolam therapy in children. Pediatr Crit Care Med 2012;13:e48-50.
39. Sumpter AL, Holford NHG. Predicting weight using postmenstrual age-neonates to adults. Pediatr Anesth 2011;21:309-15.
40. Stephenson T. How children's responses to drugs differ from adults. Br J Clin Pharmacol 2005;59:670-3.
41. Sheiner L, Tozer T. Clinical pharmacokinetics: the use of plasma concentrations of drugs. In: Melmon K, Morelli H. eds. Clinical pharmacology: basic principles of therapeutics. New York: Macmillan, 1978:71-109.
42. Holford N. Dosing in children. Clin Pharmacol Ther 2010;87:367-70.
43. Avramis VI, Spence SA. Clinical pharmacology of asparaginases in the United States: asparaginase population pharmacokinetic and pharmacodynamic (PK-PD) models (NONMEM) in adult and pediatric ALL patients. J Pediatr Hematol Oncol 2007;29:239-47.